Manufacturing, Supply and Three Paths for Global Partnerships
With seven subsidiaries, 54 trademarks and three patents, the Group’s international business centers on manufacturing and supply. From 2026 onward, its development will focus on custom OEM / ODM manufacturing, raw material supply and private-label delivery, serving brand owners, manufacturers and distributors with different product and market needs.
Today: Manufacturing and Supply at the Core The Group currently has seven subsidiaries, 54 trademarks and three patents. For international trade customers, however, its primary role is that of a manufacturer and supplier. Each subsidiary has a defined function. The research and development team handles formulation development, efficacy evaluation and the transfer of processes into production. The manufacturing team undertakes large-scale production of dermal fillers, anti-aging products and skincare products, supported by cleanrooms, automated filling lines and a batch traceability system. The supply chain team manages raw material procurement, incoming quality inspection and batch management. The sales team serves overseas brand owners, distributors and medical aesthetics providers, handling OEM / ODM orders and raw material supply. The Group’s own brands are primarily used to validate the feasibility of formulations and manufacturing processes. Proven solutions are then developed into a menu of customization options that customers can select directly, rather than forming the core of the Group’s international trade business. Looking Ahead: Custom Manufacturing, Raw Material Supply and Private-Label Delivery The next phase of international trade development will focus on three business lines. Custom Manufacturing Products will be selected according to the category requirements of each customer’s target market. Services will span formulation design, sample development and the preparation of registration documentation, covering two main categories: facial filling and rejuvenation. Raw Material Supply The Group will supply intermediate materials, including cross-linked hyaluronic acid gel, recombinant collagen and PLLA microspheres, to overseas brands and manufacturers. Standardized specifications and batch-to-batch consistency will be the key performance criteria. Private-Label Delivery Building on established formulations, the Group will work with customers to localize packaging and labeling, shortening the time from order placement to market launch. These three business lines address the needs of brand owners seeking differentiated products, manufacturers with their own production lines, and distributors prioritizing speed to market, respectively.
Read More



